Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
Leukemia|October 28, 2025
Different immunotherapeutic combinations enhance specific T cell immune responses against leukemic cells, as well as leukemic progenitor cells, in acute myeloid leukemiaJochen Greiner, Patrick J Schuler, Hubert Schrezenmeier, et al.
International Journal of Cancer|December 30, 2003
mRNA expression of leukemia-associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapiesJochen Greiner, Mark Ringhoffer, Masanori Taniguchi, et al.
Cancer Immunology, Immunotherapy : CII|October 7, 2015
Analogue peptides for the immunotherapy of human acute myeloid leukemiaSusanne Hofmann, Andrew Mead, Aleksandrs Malinovskis, et al.
The Journal of Urology|May 6, 2004
Simultaneous expression of T-cell activating antigens in renal cell carcinoma: implications for specific immunotherapyMark Ringhoffer, Carlheinz R Müller, Ariane Schenk, et al.
Plant Physiology|July 5, 2008
Comparative proteomics of chloroplast envelopes from C3 and C4 plants reveals specific adaptations of the plastid envelope to C4 photosynthesis and candidate proteins required for maintaining C4 metabolite fluxesAndrea Bräutigam, Susanne Hoffmann-Benning, Susanne Hofmann-Benning, et al.
Theranostics|May 23, 2017
Peptide vaccination in the presence of adjuvants in patients after hematopoietic stem cell transplantation with CD4+ T cell reconstitution elicits consistent CD8+ T cell responsesMichael Schmitt, Anita Schmitt, Markus Wiesneth, et al.
Cancers|October 26, 2024
Immunotherapeutic Potential of Mutated NPM1 for the Treatment of Acute Myeloid LeukemiaJochen Greiner, Eithar Mohamed, Daniel M Fletcher, et al.
British Journal of Haematology|March 22, 2003
Expression of human leucocyte antigens and co-stimulatory molecules on blasts of patients with acute myeloid leukaemiaMarkus Vollmer, Li Li, Anita Schmitt, et al.
International Journal of Molecular Sciences|October 13, 2021
Survivin' Acute Myeloid Leukaemia-A Personalised Target for inv(16) PatientsJochen Greiner, Elliott Brown, Lars Bullinger, et al.
Molecular Cancer|February 2, 2010
Effects of nilotinib on regulatory T cells: the dose mattersFei Fei, Yingzhe Yu, Anita Schmitt, et al.
Pageof 9